Guangzhou Jet Bio-Filtration Co., Ltd. (SHA:688026)

Market Cap	2.56B +51.7%
Revenue (ttm)	566.02M +8.0%
Net Income	79.32M +11.7%
EPS	0.53 -5.6%
Shares Out	137.63M
PE Ratio	35.08
Forward PE	n/a
Dividend	0.07 (0.39%)
Ex-Dividend Date	Jul 2, 2025

Volume	1,607,223
Average Volume	1,838,788
Open	18.80
Previous Close	18.77
Day's Range	18.56 - 18.98
52-Week Range	11.58 - 21.66
Beta	0.75
RSI	64.10
Earnings Date	Apr 23, 2026

About SHA:688026

Guangzhou Jet Bio-Filtration Co., Ltd. researches, develops, manufactures, and sells biological laboratory consumable products. Its products include bioprocess, biological culture, liquid handling and storage, filtration products, molecular biology, cellsafe, medical consumables, biological reagents, laboratory equipment, petri dishes, ELISA plates, immuno micro plates, inoculating loops and needles, cuvettes, latex powder-free gloves, NBR gloves, and other products. The company was founded in 2001 and is headquartered in Guangzhou, China.

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2001
• Employees: 990
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688026

Financial Performance

In 2024, SHA:688026's revenue was 558.66 million, an increase of 20.63% compared to the previous year's 463.10 million. Earnings were 72.19 million, an increase of 107.51%.